Visual Acuity of Patients after Neodymium:Yttrium-Aluminium-Garnet Laser at Cicendo Eye Hospital in 2013-2014

Authors

  • Lee Pei Yie
  • Budiman Budiman
  • Ihrul Prianza Prajitno

Keywords:

Nd, YAG laser, posterior capsule opacification, visual acuity

Abstract

Background: Indonesia ranks the second highest in blindness worldwide. One of the factors that may cause blindness is posterior capsule opacification (PCO), a secondary cataract that developed after cataract surgery. PCO eventually leads to visual impairment. The common management for PCO is neodymium:yttrium-aluminium-garnet (Nd:YAG) laser posterior capsulotomy. It is an effective, non-invasive, and painless procedure. The aim of this study was to describe the visual acuity of PCO patients after Nd: YAG laser posterior capsulotomy.

Methods: A descriptive study was conducted based on simple randomized secondary data from Cicendo Eye Hospital, Bandung from January 2013 to August 2014.

Results: Out of 102 patients, 53 patients (51.96%) were male and 49 (48.04%) were females. The male to female ratio was 1:1. The maximum number of patients was at age group of 60−69 years (33.33%). Sixty−nine patients (67.65%) presented mild or no visual impairment uncorrected visual acuity (UCVA) post-laser. Eighty-nine patients (87.25%) presented mild or no visual impairment best-corrected visual acuity (BCVA) post-laser. Generally, 94 patients (92.16%) showed improvement of visual acuity after Nd:YAG laser posterior capsulotomy. Three patients (2.49%) were suffering from blindness UCVA post-laser and 1 patient (0.98%) falls at blindness BCVA post-laser respectively.

Conclusions: Improvement of visual acuity is achieved after Nd:YAG laser posterior capsulotomy in PCO patients. [AMJ.2016;3(1):99–102]


DOI: 10.15850/amj.v3n1.719

References

WHO. Visual impairment and blindness. 2013 [cited 2014 October 28]. Available from: http://www.who.int/mediacentre/factsheets/fs282/en/index.html.

Vision 2020 Australia. Towards 2020. 2010 [cited 2014 October 28]. Available from: http://www.vision2020australia.org.au/.

Wormstone IM, Wride MA. The ocular lens: a classic model for development, physiology and disease. Philos Trans R Soc Lond B Biol Sci. 2011;366(1568):1190−2.

Hashemi H, Mohammadi SF, Majdi M, Fotouhi A, Khabazkhoob M. Posterior capsule opacification after cataract surgery and its determinants. Iranian Journal of Ophthalmology. 2012;24(2):3−8.

Khanzada MA, Jatoi SM, Narsani AK, Dabir SA, Gul S. Is the Nd:YAG laser a safe procedure for posterior capsulotomy. Pak J Ophthalmol. 2008;24(2):73−8.

Bari KN. Nd:YAG laser posterior capsulotomy and visual outcome. Delta Med Col J. 2013;1(1):16−9.

Ajite KO, Ajayi IA, Omotoye OJ, Fadamiro CO. Visual outcome of patients with posterior capsular opacificationn treated with Nd:YAG laser. JMMR. 2013;1(4):23−7.

Hawlina G, Olup BD. Nd: YAG laser capsulotomy for treating posterior capsule opacification. Journal of the Laser and Health Academy. 2013;2013(1):S34−S5.

Gupta ML. Visual benefits of nd yag laser capsulotomy study in South Eastern Rajasthan. Int J Biol Med Res. 2012;3(4):2507−14.

Gregor VS. The sudy of complications of Nd:YAG laser capsulotomy. Int J Bioinformatics Res. 2012;4(2):265−8.

Downloads

Published

2016-03-29

Issue

Vol. 3 No. 1 (2016)

Section

Articles

License

  1. Authors retain copyright and grant Althea Medical Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in Althea Medical Journal. Althea Medical Journal is licensed under CC BY-NC 4.0
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Althea Medical Journal.